TITLE:
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

CONDITION:
Insomnia

INTERVENTION:
MK0928, gaboxadol / Duration of Treatment - 1 year

SUMMARY:

      The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with
      insomnia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 64 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of insomnia
      
